Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $480.22 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $144.57 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $124.99 | 1 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $102.55 | 1 | $0 (2017) |
| ABBVIE INC. | $70.50 | 4 | $0 (2024) |
| Genentech USA, Inc. | $37.61 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.13 | 1 | ABBVIE INC. ($17.13) |
| 2023 | $53.37 | 3 | ABBVIE INC. ($53.37) |
| 2022 | $124.99 | 1 | AstraZeneca Pharmaceuticals LP ($124.99) |
| 2019 | $144.74 | 3 | Allergan Inc. ($121.13) |
| 2018 | $37.44 | 2 | Allergan Inc. ($23.44) |
| 2017 | $102.55 | 1 | E.R. Squibb & Sons, L.L.C. ($102.55) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/19/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/12/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/11/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/25/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Rare Disease | ||||||
| 04/26/2019 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Metabolism & Primary Care | ||||||
| 03/20/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/13/2019 | Genentech USA, Inc. | Activase (Biological), Xofluza | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Metabolism & Primary Care | ||||||
| 10/11/2018 | Genentech USA, Inc. | Activase (Biological), Cathflo Activase | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Metabolism & Primary Care | ||||||
| 10/10/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/15/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $102.55 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 672 | 693 | $1.1M | $93,393 |
| 2022 | 4 | 604 | 613 | $964,096 | $86,030 |
| 2021 | 4 | 670 | 691 | $1.1M | $99,872 |
| 2020 | 4 | 659 | 683 | $1.1M | $96,912 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 485 | 503 | $872,704 | $72,850 | 8.3% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 133 | 136 | $161,098 | $13,590 | 8.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 32 | 32 | $59,960 | $5,666 | 9.4% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 22 | 22 | $16,786 | $1,287 | 7.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 461 | 470 | $791,540 | $70,043 | 8.8% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 85 | 85 | $97,767 | $8,793 | 9.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 30 | 30 | $53,668 | $5,534 | 10.3% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 28 | 28 | $21,121 | $1,660 | 7.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 467 | 486 | $817,452 | $74,943 | 9.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 117 | 118 | $135,582 | $12,676 | 9.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 52 | 53 | $94,499 | $10,254 | 10.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 34 | 34 | $25,636 | $1,998 | 7.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 471 | 492 | $827,544 | $73,327 | 8.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 57 | 59 | $105,197 | $11,577 | 11.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 104 | 105 | $120,645 | $10,582 | 8.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 27 | 27 | $20,358 | $1,426 | 7.0% |
About Dr. Charles Nolte, D.O
Dr. Charles Nolte, D.O is a Emergency Medicine healthcare provider based in Stratford, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1134329865.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Nolte, D.O has received a total of $480.22 in payments from pharmaceutical and medical device companies, with $17.13 received in 2024. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($480.22).
As a Medicare-enrolled provider, Nolte has provided services to 2,605 Medicare beneficiaries, totaling 2,680 services with total Medicare billing of $376,207. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Stratford, NJ
- Active Since 07/20/2007
- Last Updated 03/29/2017
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134329865
Products in Payments
- DALVANCE (Drug) $191.63
- ANDEXXA (Biological) $124.99
- ELIQUIS (Drug) $102.55
- Activase (Biological) $37.61
- AVYCAZ (Drug) $23.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Stratford
Dr. Jonas Salna, Do, DO
Emergency Medicine — Payments: $1,054
Dr. Andrew Vasta, D.o, D.O
Emergency Medicine — Payments: $1,011
Dr. Giovanna Finocchio, Do, DO
Emergency Medicine — Payments: $702.88
Dr. James Lee, Do, DO
Emergency Medicine — Payments: $650.42
Henry Schuitema, Do, DO
Emergency Medicine — Payments: $619.25
Daniel Ellis, Md, MD
Emergency Medicine — Payments: $413.89